•  
  •  
  •  
  •  

2025-12-23 14:28:46

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  KelltonTechSolutions

Stock Report

  • Kellton Tech Solutions Ltd to acquire Kumori Technologies Services Pvt Ltd
  • Kellton secures $2.5 Million project from Oil India to transform Wellhead Monitoring
  • Kellton Tech Solutions Ltd Q1 FY2024-25 net profit at Rs. 19.94 crores
  • Kellton recognized as a 'Challenger' in Avasant's SAP S/4HANA Services 2023-2024 RadarViewâ„¢
  • LIC embarks on a Digital Transformation Journey with Kellton as its strategic HRMS partner
  • Karnataka State Government's Finance Department partners with Kellton to develop Human Resource Management System version 2.0
  • Kellton debuts as Leader in 2022 Zinnov Zones ER&D Services Report
  • Vividh Baru joins Kellton as the Global Head of Digital Practice
  • Kellton Tech Q2 FY23 Revenue at Rs. 2278.5 Million; up 9.1% YoY
  • Kellton Tech promotes Mr. Sumit Chachra as Chief Technical Officer and Dr. Srinivas Bandi as SVP - Enterprise Solutions
  • Kellton Tech Solutions Ltd reports Q4FY22, FY2022 results
  • Kellton Tech announces Strategic Business Restructuring
  • Kellton Tech Solutions Q3FY22 consolidated PAT at Rs. 16.98 crores
  • Kellton Tech to provide HMWSSB with IoT-based enterprise intelligence and analytics solutions

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024